HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of amelioration of insulin resistance by beta3-adrenoceptor agonist AJ-9677 in the KK-Ay/Ta diabetic obese mouse model.

Abstract
The mechanism by which the specific beta3-adrenoceptor agonist AJ-9677 relieves insulin resistance in vivo was investigated by studying its effects in the white and brown adipose tissues of the KK-Ay/Ta diabetic obese mouse model. AJ-9677 reduced the total weight of white adipose tissues by reducing the size of the adipocytes, an effect associated with the normalization of tumor necrosis factor-alpha (TNF-alpha) and leptin expression levels. The levels of uncoupling protein (UCP)-1 mRNA in brown adipose tissue were increased threefold. AJ-9677 caused a marked increase (20- to 80-fold) in the expression of UCP-1 in white adipose tissues. The levels of UCP-2 mRNA were increased in both the white and brown adipose tissues of diabetic obese mice, and AJ-9677 further upregulated UCP-2 mRNA levels in brown adipose tissue, but reduced its levels in white adipose tissue. UCP-3 mRNA levels were not essentially changed by AJ-9677. However, AJ-9677 significantly (two- to four-fold) upregulated the GLUT4 mRNA and protein levels in white and brown adipose tissues and the gastrocnemius. The generation of small adipocytes, presumably mediated by increased expression of UCP-1 in addition to increased lipolysis in response to AJ-9677, was associated with decreased TNF-alpha and free fatty acid production and may be the mechanism of amelioration of insulin resistance in KK-Ay/Ta diabetic obese mice.
AuthorsH Kato, M Ohue, K Kato, A Nomura, K Toyosawa, Y Furutani, S Kimura, T Kadowaki
JournalDiabetes (Diabetes) Vol. 50 Issue 1 Pg. 113-22 (Jan 2001) ISSN: 0012-1797 [Print] United States
PMID11147775 (Publication Type: Journal Article)
Chemical References
  • ((3-((2R)-(((2R)-3-chlorophenyl)-2-hydroxyethyl)amino)propyl)-1H-indol-7-yloxy)acetic acid
  • Acetates
  • Adrenergic beta-Agonists
  • Blood Glucose
  • Carrier Proteins
  • Fatty Acids, Nonesterified
  • Glucose Transporter Type 4
  • Indoles
  • Insulin
  • Ion Channels
  • Leptin
  • Membrane Proteins
  • Membrane Transport Proteins
  • Mitochondrial Proteins
  • Monosaccharide Transport Proteins
  • Muscle Proteins
  • Proteins
  • RNA, Messenger
  • Slc2a4 protein, mouse
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Ucp1 protein, mouse
  • Ucp2 protein, mouse
  • Ucp3 protein, mouse
  • Uncoupling Protein 1
  • Uncoupling Protein 2
  • Uncoupling Protein 3
Topics
  • Acetates
  • Adipose Tissue (drug effects, pathology)
  • Adrenergic beta-Agonists (pharmacology)
  • Animals
  • Blood Glucose (analysis)
  • Carrier Proteins (metabolism)
  • Diabetes Mellitus (genetics, pathology, physiopathology)
  • Fatty Acids, Nonesterified (blood)
  • Glucose Transporter Type 4
  • Indoles (pharmacology)
  • Insulin (blood)
  • Insulin Resistance
  • Ion Channels
  • Leptin (genetics, metabolism)
  • Membrane Proteins (metabolism)
  • Membrane Transport Proteins
  • Mice
  • Mitochondrial Proteins
  • Monosaccharide Transport Proteins (metabolism)
  • Muscle Proteins
  • Obesity
  • Proteins (metabolism)
  • RNA, Messenger (metabolism)
  • Triglycerides (blood)
  • Tumor Necrosis Factor-alpha (genetics, metabolism)
  • Uncoupling Protein 1
  • Uncoupling Protein 2
  • Uncoupling Protein 3

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: